Yoko Fujita-Yamaguchi, Ph.D.

Beckman Research Institute of the City of Hope
email: Yyamaguchi@coh.Org

Grants

Receptor Antibody-Enhanced Chemotherapy for Breast Cancer 1997 (Cycle III)
ITaMoCAs 3CB-0186 $347,674


A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues
  Periodical: Growth Horm IGF Res
  Author(s): Fichera E, Liang S, Xu Z, Guo N, Mineo R, Fujita-Yamaguchi Y.
  Yr: 2000 Vol: 10 Nbr: 2 Pgs: 61-70
  Associated Grant: Receptor Antibody-Enhanced Chemotherapy for Breast Cancer
 
Promoter Usage for Insulin-Like Growth Factor-II in Cancerous and Benign Human Breast, Prostate, and Bladder Tissues, and Confirmation of a 10th Exon.
  Periodical: Biochemistry and Biophysics Research Communications
  Author(s): Mineo, R., Fichera, E., Liang, S.-J., and Fujito-Yamaguchi, Y.
  Yr: 2000 Vol: 268 Nbr: 3 Pgs: 886-92
  Associated Grant: Receptor Antibody-Enhanced Chemotherapy for Breast Cancer
 
Single chain antibodies against human insulin-like growth factor-I receptor: Expression, purification, and effect on tumor growth.
  Periodical: Cancer Immunology Immunotherapy
  Author(s): Li, S.-L., Liang, S.-J., Guo, N., Wu, A.M., Fujita-Yamaguchi, Y.
  Yr: 2000 Vol: 49 Nbr: 4-5 Pgs: 243-52
  Associated Grant: Receptor Antibody-Enhanced Chemotherapy for Breast Cancer